愛爾眼科醫(yī)院集團是知名全球連鎖眼科醫(yī)療機構(gòu)，IPO上市醫(yī)療機構(gòu)（股票代碼: 300015，2015年入選滬深300指數(shù)股）。截至2019年，已在中國大陸30個省市區(qū)建立290余家專業(yè)眼科醫(yī)院，覆蓋全國醫(yī)保人口超過70%，年門診量超過650 萬人。并且，在美國、歐洲和香港開設有80余家眼科醫(yī)院。 　　Aier eye hospital group is a well-known global chain of eye hosp******** an******** also China's first IPO liste******** institution (stock code: 300015, one of the CSI 300 index selecte******** 2015). As of 2019, Aier Eye Hospital Group has establishe******** than 290 specialize******** hospitals covering 30 provinces an******** our services to 70% of insure******** all over the country with over 6.5 million outpatient visits annually. Recently, There are more than 80 ophthalmic branches in the Unite********, Europe an********. 　　愛爾眼科致力于引進和吸收國際同步的眼科技術(shù)與醫(yī)療管理理念，以專業(yè)化、規(guī)?；?、科學化為發(fā)展戰(zhàn)略，推動中國眼科醫(yī)療事業(yè)的發(fā)展。 　　Aier is committe******** the parallel introduction an******** of world-leading ophthalmic technology an******** concept, with profess******** scale an******** as its strategy to advance the development of China's ophthalmic medical care.